SCHEMBL3172356

SCHEMBL3172356

CC(=O)NCCNc1cc(N2CCN(C(=O)c3ccc(C)c(O)c3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 2/20 0.44
KDM2B Q8NHM5 2/20 0.43
KDM6B O15054 2/20 0.43
NR1I2 O75469 1/20 0.43
CHRNA1 P02708 1/20 0.43
MAOB P27338 1/20 0.43
OPRM1 P35372 1/20 0.43
AHR P35869 1/20 0.43
AVPR1A P37288 1/20 0.43
OPRK1 P41145 1/20 0.43
PDE4B Q07343 1/20 0.43
SCN5A Q14524 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
KDM5B Q9UGL1 1/20 0.43
PHF8 Q9UPP1 1/20 0.43
SLCO1B1 Q9Y6L6 1/20 0.43
ADORA2B P29275 3/20 0.42
ADORA2A P29274 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165387 0.92 GBA1 (0.45) GBA1ALDH1A1LMNAADORA3TSHR
SCHEMBL3172414 0.89 GBA1 (0.50) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3171321 0.89 GBA1 (0.54) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3155347 0.89 GBA1 (0.49) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3166838 0.89 MGLL (0.49) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3166309 0.88 GBA1 (0.48) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3175693 0.88 LMNA (0.45) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3164343 0.88 GBA1 (0.52) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3175804 0.88 GBA1 (0.51) GBA1ALDH1A1LMNAKDM2BKDM6B
SCHEMBL3163851 0.88 GBA1 (0.48) GBA1ALDH1A1LMNAKDM2BKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed